BindingDB logo
myBDB logout

null

SMILES: O[C@H]1CC[C@H](CC1)Nc1nccc(n1)-n1ccc2c(cccc12)N1CCN(CC1)C(=O)CC#N

InChI Key: InChIKey=WMOAJNNZXGCJHX-KDURUIRLSA-N

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 102608   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Mitogen-activated protein kinase 8


(Homo sapiens (Human))
BDBM102608
PNG
(US8536172, I-57)
Show SMILES O[C@H]1CC[C@H](CC1)Nc1nccc(n1)-n1ccc2c(cccc12)N1CCN(CC1)C(=O)CC#N |r,wU:4.7,1.0,(-7.55,-4,;-7.55,-2.46,;-8.89,-1.69,;-8.89,-.15,;-7.55,.62,;-6.22,-.15,;-6.22,-1.69,;-7.55,2.16,;-6.22,2.93,;-6.22,4.47,;-4.89,5.24,;-3.55,4.47,;-3.55,2.93,;-4.89,2.16,;-2.22,2.16,;-.76,2.64,;.15,1.39,;-.76,.14,;-.44,-1.36,;-1.58,-2.39,;-3.04,-1.92,;-3.36,-.41,;-2.22,.62,;1.05,-1.76,;1.45,-3.25,;2.94,-3.65,;4.03,-2.56,;3.63,-1.07,;2.14,-.67,;5.51,-2.96,;6.6,-1.87,;5.91,-4.44,;7.4,-4.84,;8.89,-5.24,)|
Show InChI InChI=1S/C25H29N7O2/c26-11-8-24(34)31-16-14-30(15-17-31)21-2-1-3-22-20(21)10-13-32(22)23-9-12-27-25(29-23)28-18-4-6-19(33)7-5-18/h1-3,9-10,12-13,18-19,33H,4-8,14-17H2,(H,27,28,29)/t18-,19+
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
n/an/a 88.4n/an/an/an/a7.5n/a



Roche Palo Alto LLC

US Patent


Assay Description
JNK activity was measured by phosphorylation of GST-ATF2 (19-96) with [gamma-33P] ATP.


US Patent US8536172 (2013)


BindingDB Entry DOI: 10.7270/Q23N222K
More data for this
Ligand-Target Pair
Mitogen-activated protein kinase 8


(Homo sapiens (Human))
BDBM102608
PNG
(US8536172, I-57)
Show SMILES O[C@H]1CC[C@H](CC1)Nc1nccc(n1)-n1ccc2c(cccc12)N1CCN(CC1)C(=O)CC#N |r,wU:4.7,1.0,(-7.55,-4,;-7.55,-2.46,;-8.89,-1.69,;-8.89,-.15,;-7.55,.62,;-6.22,-.15,;-6.22,-1.69,;-7.55,2.16,;-6.22,2.93,;-6.22,4.47,;-4.89,5.24,;-3.55,4.47,;-3.55,2.93,;-4.89,2.16,;-2.22,2.16,;-.76,2.64,;.15,1.39,;-.76,.14,;-.44,-1.36,;-1.58,-2.39,;-3.04,-1.92,;-3.36,-.41,;-2.22,.62,;1.05,-1.76,;1.45,-3.25,;2.94,-3.65,;4.03,-2.56,;3.63,-1.07,;2.14,-.67,;5.51,-2.96,;6.6,-1.87,;5.91,-4.44,;7.4,-4.84,;8.89,-5.24,)|
Show InChI InChI=1S/C25H29N7O2/c26-11-8-24(34)31-16-14-30(15-17-31)21-2-1-3-22-20(21)10-13-32(22)23-9-12-27-25(29-23)28-18-4-6-19(33)7-5-18/h1-3,9-10,12-13,18-19,33H,4-8,14-17H2,(H,27,28,29)/t18-,19+
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
n/an/a 15.9n/an/an/an/a7.5n/a



Roche Palo Alto LLC

US Patent


Assay Description
JNK activity was measured by phosphorylation of GST-ATF2 (19-96) with [gamma-33P] ATP.


US Patent US8536172 (2013)


BindingDB Entry DOI: 10.7270/Q23N222K
More data for this
Ligand-Target Pair